105 related articles for article (PubMed ID: 6597562)
1. Basic design of beta-lactam antibiotics--cephalosporins.
Price KE; McGregor DN
Scand J Infect Dis Suppl; 1984; 42():50-63. PubMed ID: 6597562
[TBL] [Abstract][Full Text] [Related]
2. [Review of oral cephalosporins. Basis for a rational choice].
Forti IN
Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
[TBL] [Abstract][Full Text] [Related]
3. Trends in the development of beta-lactam antibiotics.
Neu HC
Scand J Infect Dis Suppl; 1984; 42():7-16. PubMed ID: 6597563
[TBL] [Abstract][Full Text] [Related]
4. Newer cephalosporins and cephamycins--a review.
Norrby R
Scand J Infect Dis Suppl; 1978; (13):83-7. PubMed ID: 356183
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
6. A novel series of parenteral cephalosporins exhibiting potent activities against both Pseudomonas aeruginosa and other gram-negative pathogens. Part 2: Synthesis and structure-activity relationships.
Yamawaki K; Nomura T; Yasukata T; Tanimoto N; Uotani K; Miwa H; Yamano Y; Takeda K; Nishitani Y
Bioorg Med Chem; 2008 Feb; 16(4):1632-47. PubMed ID: 18065229
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review.
Bijie H; Kulpradist S; Manalaysay M; Soebandrio A
J Chemother; 2005 Feb; 17(1):3-24. PubMed ID: 15828439
[TBL] [Abstract][Full Text] [Related]
8. Cefepime: a new fourth-generation cephalosporin.
Okamoto MP; Nakahiro RK; Chin A; Bedikian A; Gill MA
Am J Hosp Pharm; 1994 Feb; 51(4):463-77; quiz 541-2. PubMed ID: 8017411
[TBL] [Abstract][Full Text] [Related]
9. [Clinical use of new cephalosporins for severe infections in internal medicine].
Stille W
Wien Klin Wochenschr Suppl; 1983; 142():18-20. PubMed ID: 6316668
[TBL] [Abstract][Full Text] [Related]
10. Novel cephalosporin derivatives possessing a substituted cinnamoyl moiety at the 7 beta-position. Synthesis, structural characterization and antibacterial activity of 3-acetoxymethyl cephalosporin derivatives.
López MA; Rodríguez Z; González M; Tolón B; Avila R; González I; Garmendía L; Mamposo T; Carrasco R; Pellón R; Vélez H; Fini A
Eur J Med Chem; 2004 Aug; 39(8):657-64. PubMed ID: 15276299
[TBL] [Abstract][Full Text] [Related]
11. The selection and use of cephalosporins: a review.
Klein NC; Cunha BA
Adv Ther; 1995; 12(2):83-101. PubMed ID: 10150326
[TBL] [Abstract][Full Text] [Related]
12. A novel series of parenteral cephalosporins exhibiting potent activities against Pseudomonas aeruginosa and other Gram-negative pathogens: synthesis and structure-activity relationships.
Yamawaki K; Nomura T; Yasukata T; Uotani K; Miwa H; Takeda K; Nishitani Y
Bioorg Med Chem; 2007 Nov; 15(21):6716-32. PubMed ID: 17723304
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with extended-spectrum beta-lactamase-producing organisms at a tertiary care hospital.
Graffunder EM; Preston KE; Evans AM; Venezia RA
J Antimicrob Chemother; 2005 Jul; 56(1):139-45. PubMed ID: 15917283
[TBL] [Abstract][Full Text] [Related]
14. Correlation between structure and biological properties of cephalosporins: the discovery of ceftriaxone.
Reiner R
Drugs Exp Clin Res; 1986; 12(4):299-302. PubMed ID: 3522153
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
Fass RJ
Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
[TBL] [Abstract][Full Text] [Related]
16. [Microbiological aspects of antibiotics with immunomodulating action].
Schito GC; Debbia EA; Nicoletti G; Blandino G; Cocuzza G; Dainelli B; Maida A
J Chemother; 1994 Aug; 6 Suppl 3():19-22. PubMed ID: 7861204
[TBL] [Abstract][Full Text] [Related]
17. Appropriate prescribing of oral beta-lactam antibiotics.
Holten KB; Onusko EM
Am Fam Physician; 2000 Aug; 62(3):611-20. PubMed ID: 10950216
[TBL] [Abstract][Full Text] [Related]
18. Symposium on antimicrobial therapy. IV. The cephalosporins.
Greenfield RA
J Okla State Med Assoc; 1993 Jan; 86(1):7-12. PubMed ID: 8426246
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activities of third-generation cephalosporins.
Fass RJ
Arch Intern Med; 1983 Sep; 143(9):1743-5. PubMed ID: 6615095
[TBL] [Abstract][Full Text] [Related]
20. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
